Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of modified release AFQ056 in patients that
have Parkinson's Disease L-dopa Induced Dyskinesias (PD-LID)